Syncona Ltd, a leading life sciences company headquartered in Great Britain, focuses on building and financing innovative biotechnology businesses. Founded in 2016, Syncona has rapidly established itself in the healthcare sector, particularly in the development of advanced therapies and regenerative medicine. With a strong operational presence in the UK and the US, Syncona is dedicated to creating and supporting companies that address significant unmet medical needs. Its unique approach combines deep scientific expertise with strategic investment, enabling the development of cutting-edge products and services. Notable achievements include a robust portfolio of companies that are pioneering breakthroughs in gene therapy and cell therapy. Syncona's commitment to innovation positions it as a key player in the life sciences industry, driving advancements that have the potential to transform patient care.
How does Syncona's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Services Auxiliary to Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Syncona's score of 30 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Syncona reported total carbon emissions of approximately 492,330 kg CO2e, with Scope 1 emissions at 930 kg CO2e and Scope 3 emissions at about 491,400 kg CO2e. The significant contributors to Scope 3 emissions included business travel, which accounted for approximately 480,500 kg CO2e, and employee commuting, contributing about 5,780 kg CO2e. For 2023, the total emissions were approximately 192,640 kg CO2e, with Scope 1 emissions at 740 kg CO2e and Scope 3 emissions at about 191,900 kg CO2e. Business travel again represented a major portion of Scope 3 emissions, at approximately 176,010 kg CO2e. In 2022, Syncona's emissions in the UK were approximately 65,000 kg CO2e, with Scope 1 emissions at 400 kg CO2e, Scope 2 emissions at about 11,800 kg CO2e, and Scope 3 emissions at approximately 52,800 kg CO2e. Despite these figures, Syncona has not set specific reduction targets or initiatives as part of their climate commitments, and there are no reported SBTi (Science Based Targets initiative) reduction targets. The company has not disclosed any significant climate pledges or reduction initiatives, indicating a potential area for future development in their sustainability strategy. All emissions data is sourced directly from Syncona Limited, with no cascaded data from parent or related organizations.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 700 | 000 | 000 |
| Scope 2 | - | - | - |
| Scope 3 | 53,200 | 000,000 | 000,000 |
Syncona's Scope 3 emissions, which increased by 156% last year and increased by approximately 824% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Business Travel" being the largest emissions source at 98% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Syncona has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

